Treatment options in stage III non-small cell lung cancer.

Lung cancer is responsible for over 1 million deaths annually, worldwide. The disease becomes symptomatic in advanced stages, so the diagnosis is delayed and 90% of cases cannot benefit from a curative treatment. In NSCLC surgical resection represents the best option for long term survival in resectable stage III and in clinical stage I/II.

Benefits of a 7-week outpatient pulmonary rehabilitation program in COPD patients.

Background: Respiratory rehabilitation programs (RR) are essential tools in the management of COPD.

Aim: We present the results of a 7-week outpatient rehabilitation program in terms of dyspnea, exercise tolerance and quality of life.

Material And Method: The following parameters were evaluated before and after RR: dyspnea (mMRC scale), pulmonary function (FEVI, RV- residual volume), exercise tolerance (6MWT- 6 minutes walk test, CPET - cardiopulmonary exercise test), quality of life (SGROQ questionnaire).

The contribution of exercise testing in the prescription and outcome evaluation of exercise training in pulmonary rehabilitation.

Pulmonary rehabilitation is a comprehensive therapeutic intervention with proven efficacy in relieving symptoms and increasing exercise tolerance in patients with chronic respiratory diseases.One of the main components of a pulmonary rehabilitation program is lower limbs exercise training. There are several ways of establishing the optimal intensity of the exercise training, using the target heart rate, symptom scores, walking tests and laboratory exercise tests with or without ventilation or gas exchange measurements.

[Functional evaluation before lung resection for cancer--international recommendations].

Complications and disability after radical therapy for lung cancer can be predicted by preoperative functional evaluation. Functional tests and threshold values of the parameters have been described and included in a well-validated algorithm, ensuring functional reserve evaluation of candidates for pulmonary resection. There are no defined tests or cut-off values to provide predictions of complications after chemo-radiotherapy or limited pulmonary resections.